Ingredients

Headlines > All Ingredients News

Email this page News by email Send a press-release

Surface science improves metal oxide catalysis

13-Jun-2003 - A team of researchers in the USA has now taken the first steps towards the direct synthesis of designer metal oxides generated, with specific surface...

Avantium speeds up process R&D for Eastman

13-Jun-2003 - Avantium Technologies of the Netherlands, a specialist in developing high throughput process R&D techniques for customers in the chemical and pharmaceutical industries, has been signed...

Towards high-throughput proteomics

11-Jun-2003 - Bruker Daltonics has forged a collaborative research and development agreement with the US Pacific Northwest National Laboratory's Battelle Memorial Institute that will focus on the...

Improving DNA vaccine delivery

09-Jun-2003 - The USA's Nature Technology has launched an improved delivery technology for DNA vaccines that is now available for license by companies working in this fast-growing...

Oligo licence for Transgenomic

06-Jun-2003 - Transgenomic has taken out a non-exclusive licence from Geron in which it gains manufacturing rights to phosphoramidate and thio-phosphoramidate oligonucleotides. The licence also covers the...

US patent for pressure-sensitive reaction system

06-Jun-2003 - US firm Boston Biomedica has been issued an additional US patent covering the design and use of its Pressure Cycling Technology for the control of...

New science chief at METabolic EXplorer

05-Jun-2003 - METabolic EXplorer, a French biotechnology company specialising in the development and production of new biological processes for the manufacturing of chemicals and pharmaceuticals, has bolstered...

AstraZeneca takes on TB in India

03-Jun-2003 - AstraZeneca has opened a new multi-million dollar research facility in Bangalore, India, which will focus principally on finding new treatments for tuberculosis, a disease which...

Merck restructures R&D as diabetes drugs fail

02-Jun-2003 - Germany-based drugmaker Merck KGaA has launched a major restructuring of its R&D activities after shelving two of its early-stage diabetes product candidates, EML 16336, an...

Irish drug industry must attract more process development

02-Jun-2003 - A science and technology advisory group has called on the Irish government to ensure that the country remains competitive in the pharmaceutical and chemical industries...

Schwarz to slash staff in Ireland

30-May-2003 - Local press reports in Ireland have suggested that Germany's Schwarz Pharma is planning to scale back its operations in Shannon and cut its workforce. The...

Acceptys licenses cell line for Ab production

30-May-2003 - US biopharmaceutical firm Acceptys has licensed an immortal humanised cell line from Columbia University, which will allow it to discover and produce fully human monoclonal...

Nanoarray patent awarded to BioForce

28-May-2003 - BioForce Nanosciences of the USA has been granted a US patent covering nanoscale arrays useful in identifying target materials or for characterising molecular interaction events....

Saxony aims to be new Euro bio hub

26-May-2003 - The German state of Saxony has implemented a $230 million, five-year investment program in a bid to nurture the development of 'biosaxony,' centring on the...

New flu vaccine process from Solvay

26-May-2003 - Belgian pharmaceutical and chemicals firm Solvay expects to launch a new version of its Influvac brand flu vaccine, based on a novel cell-based production process,...

Amarin and HEXAL in formulation deal

26-May-2003 - Sweden's Amarin Development has been commissioned by GEA Farmaceutisk Fabrik, a Danish subsidiary of German pharmaceutical company HEXAL, to develop a formulation of one of...

BASF boosts ingredient manufacturing business

23-May-2003 - BASF AG's Fine Chemicals division is expanding production of pharmaceutical active ingredients with the construction of a new plant at its site in Minden, Germany....

New facilities to feed active ingredient

23-May-2003 - New bulk drug manufacturing facilities, worth a total of around €123 million (£90 million), were officially opened this week at AstraZeneca's Avlon Works near Bristol...

Value of European outsourcing today

21-May-2003 - "Tremendous advances in science and technology, along with the shrinking period for patent exclusivity, are creating unprecedented opportunities for the drug development industry," said chairman...

Biotech Nantes provides forum for global 'biotechnopoles'

21-May-2003 - An international conference serving global centres of excellence for biotechnology, so-called 'bio-technopoles,' life science parks and 'bio-incubators' will take place ahead of the 7th European...

New tools for BASF Plant science

21-May-2003 - BASF Plant Science, the plant biotechnology subsidiary of chemical giant BASF, has entered into an agreement with Cellectis, specialists in genome engineering and a recent...

Biohealth, understanding the market

19-May-2003 - An information day to discuss European partnering and funding opportunities for small businesses in the biohealth sector will take place on 11 June in Loos,...

Forum fuels knowledge in EU

12-May-2003 - An EU funded project is building the critical mass of knowledge required to ensure that Europe meets the Lisbon objective of becoming the world's most...

Aventis signs vaccine manufacture deal with Vivalis

12-May-2003 - Strasbourg, France-based Aventis has signed a research, option and license agreement with Vivalis of the USA for the manufacture of vaccine candidates using avian stem...

Removing red tape to free-up R&D growth

09-May-2003 - The European Commission has proposed new regulations allowing Member States to grant aid for research and development (R&D) to small and medium sized enterprises (SMEs),...